Low-dose lithium aspartate did not improve fatigue and cognitive dysfunction symptoms in long COVID. A small dose-finding study suggested higher doses might be effective, but a new trial is needed.

A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; ...

The randomized clinical trial is recruiting 50 adults ages 18 to 80 with long COVID to participate. For more information on the trial, call 716-829-5454. The placebo-controlled trial is examining the ...

Dosage may be too low He notes it is possible the randomized controlled trial was ineffective because the dose of lithium aspartate that was used was too low. “The take-home message is that very low ...

Initial trials of low-dose lithium failed to improve long COVID symptoms, but new findings suggest higher doses could offer hope for patients suffering from fatigue and cognitive impairment. Study: ...

A small dose of the nutritional supplement lithium asparate may not ease the fatigue and brain fog of Long COVID, but a larger dose might work, a new trial suggests. Photo by Adobe Stock/HealthDay ...

BUFFALO, N.Y. — A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of ...

A small dose of the nutritional supplement lithium asparate may not ease the fatigue and brain fog of Long COVID, a small, new trial involving 52 patients has found. Still, it's possible that a larger ...

THURSDAY, Oct. 3, 22024 (HealthDay News) -- A small dose of the nutritional supplement lithium asparate may not ease the fatigue and brain fog of Long COVID, a small, new trial involving 52 patients ...